84 related articles for article (PubMed ID: 8608975)
1. Bcl-2/bax mRNA expression ratio as prognostic factor in low-grade urinary bladder cancer.
Gazzaniga P; Gradilone A; Vercillo R; Gandini O; Silvestri I; Napolitano M; Albonici L; Vincenzoni A; Gallucci M; Frati L; Agliano AM
Int J Cancer; 1996 Apr; 69(2):100-4. PubMed ID: 8608975
[TBL] [Abstract][Full Text] [Related]
2. Expression and prognostic significance of LIVIN, SURVIVIN and other apoptosis-related genes in the progression of superficial bladder cancer.
Gazzaniga P; Gradilone A; Giuliani L; Gandini O; Silvestri I; Nofroni I; Saccani G; Frati L; Aglianò AM
Ann Oncol; 2003 Jan; 14(1):85-90. PubMed ID: 12488298
[TBL] [Abstract][Full Text] [Related]
3. Bcl-2, Bax and p53 expression in B-CLL in relation to in vitro survival and clinical progression.
Aguilar-Santelises M; Rottenberg ME; Lewin N; Mellstedt H; Jondal M
Int J Cancer; 1996 Apr; 69(2):114-9. PubMed ID: 8608978
[TBL] [Abstract][Full Text] [Related]
4. bcl-2/bax expression and p53 gene status in human bladder cancer: relationship to early recurrence with intravesical chemotherapy after resection.
Ye D; Li H; Qian S; Sun Y; Zheng J; Ma Y
J Urol; 1998 Dec; 160(6 Pt 1):2025-8; discussion 2029. PubMed ID: 9817315
[TBL] [Abstract][Full Text] [Related]
5. Potential role of bcl-2 and bax mRNA and protein expression in chronic hepatitis type B and C: a clinicopathologic study.
Tsamandas AC; Thomopoulos K; Zolota V; Kourelis T; Karatzas T; Ravazoula P; Tepetes K; Petsas T; Karavias D; Karatza C; Bonikos DS; Gogos C
Mod Pathol; 2003 Dec; 16(12):1273-88. PubMed ID: 14681329
[TBL] [Abstract][Full Text] [Related]
6. High Bad and Bax mRNA expression correlate with negative outcome in acute myeloid leukemia (AML).
Köhler T; Schill C; Deininger MW; Krahl R; Borchert S; Hasenclever D; Leiblein S; Wagner O; Niederwieser D
Leukemia; 2002 Jan; 16(1):22-9. PubMed ID: 11840259
[TBL] [Abstract][Full Text] [Related]
7. Reduced expression of BAX is associated with poor prognosis in patients with epithelial ovarian cancer: a multifactorial analysis of TP53, p21, BAX and BCL-2.
Schuyer M; van der Burg ME; Henzen-Logmans SC; Fieret JH; Klijn JG; Look MP; Foekens JA; Stoter G; Berns EM
Br J Cancer; 2001 Nov; 85(9):1359-67. PubMed ID: 11720475
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of Bcl-2 and Bax tumor cell expression in patients with non muscle-invasive bladder cancer receiving bacillus Calmette-Guerin immunotherapy.
Ajili F; Kaabi B; Darouiche A; Tounsi H; Kourda N; Chebil M; Manai M; Boubaker S
Ultrastruct Pathol; 2012 Feb; 36(1):31-9. PubMed ID: 22292735
[TBL] [Abstract][Full Text] [Related]
9. Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2.
Haitel A; Posch B; El-Baz M; Mokhtar AA; Susani M; Ghoneim MA; Marberger M
J Urol; 2001 May; 165(5):1481-7. PubMed ID: 11342901
[TBL] [Abstract][Full Text] [Related]
10. The prognostic significance of apoptosis-associated proteins BCL-2, BAX and BCL-X in clinical nephroblastoma.
Ghanem MA; Van der Kwast TH; Den Hollander JC; Sudaryo MK; Van den Heuvel MM; Noordzij MA; Nijman RJ; Soliman EH; van Steenbrugge GJ
Br J Cancer; 2001 Nov; 85(10):1557-63. PubMed ID: 11720445
[TBL] [Abstract][Full Text] [Related]
11. High bad and bcl-xL gene expression and combined bad, bcl-xL, bax and bcl-2 mRNA levels: molecular predictors for survival of stage 2 soft tissue sarcoma patients.
Köhler T; Würl P; Meye A; Lautenschläger C; Bartel F; Borchert S; Bache M; Schmidt H; Holzhausen HJ; Taubert H
Anticancer Res; 2002; 22(3):1553-9. PubMed ID: 12168836
[TBL] [Abstract][Full Text] [Related]
12. Expression of p53 protein and the apoptotic regulatory molecules Bcl-2, Bcl-XL, and Bax in locally advanced squamous cell carcinoma of the lung.
Shabnam MS; Srinivasan R; Wali A; Majumdar S; Joshi K; Behera D
Lung Cancer; 2004 Aug; 45(2):181-8. PubMed ID: 15246189
[TBL] [Abstract][Full Text] [Related]
13. Quantitative analysis of apoptosis-related gene expression in hepatocellular carcinoma.
Ikeguchi M; Hirooka Y; Kaibara N
Cancer; 2002 Nov; 95(9):1938-45. PubMed ID: 12404288
[TBL] [Abstract][Full Text] [Related]
14. Spontaneous apoptosis in laryngeal squamous cell carcinoma is independent of bcl-2 and bax protein expression.
Jäckel MC; Dorudian MA; Marx D; Brinck U; Schauer A; Steiner W
Cancer; 1999 Feb; 85(3):591-9. PubMed ID: 10091732
[TBL] [Abstract][Full Text] [Related]
15. [Expression of the bcl-2 and bax oncoprotein in TCC and its clinical significances].
Yang B; Gu F; Wang X
Zhonghua Wai Ke Za Zhi; 1997 Oct; 35(10):602-4. PubMed ID: 10678049
[TBL] [Abstract][Full Text] [Related]
16. Variable levels of bcl-2, bcl-x and bax mRNA in bladder cancer progression.
Gazzaniga P; Gradilone A; Silvestri I; Gandini O; Giuliani L; Vincenzoni A; Gallucci M; Frati L; Agliano AM
Oncol Rep; 1998; 5(4):901-4. PubMed ID: 9625842
[TBL] [Abstract][Full Text] [Related]
17. Apoptosis-associated markers and clinical outcome in human oral squamous cell carcinomas.
Kato K; Kawashiri S; Yoshizawa K; Kitahara H; Yamamoto E
J Oral Pathol Med; 2008 Jul; 37(6):364-71. PubMed ID: 18410312
[TBL] [Abstract][Full Text] [Related]
18. Bcl-2/Bax protein ratio predicts 5-fluorouracil sensitivity independently of p53 status.
Mirjolet JF; Barberi-Heyob M; Didelot C; Peyrat JP; Abecassis J; Millon R; Merlin JL
Br J Cancer; 2000 Nov; 83(10):1380-6. PubMed ID: 11044365
[TBL] [Abstract][Full Text] [Related]
19. Bax protein expression in colorectal cancer: association with p53, bcl-2 and patterns of relapse.
Giatromanolaki A; Sivridis E; Stathopoulos GP; Fountzilas G; Kalofonos HP; Tsamandas A; Vrettou E; Scopa C; Polychronidis A; Simopoulos K; Koukourakis MI
Anticancer Res; 2001; 21(1A):253-9. PubMed ID: 11299743
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of the death-promoting gene bax-alpha which is downregulated in breast cancer restores sensitivity to different apoptotic stimuli and reduces tumor growth in SCID mice.
Bargou RC; Wagener C; Bommert K; Mapara MY; Daniel PT; Arnold W; Dietel M; Guski H; Feller A; Royer HD; Dörken B
J Clin Invest; 1996 Jun; 97(11):2651-9. PubMed ID: 8647960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
